The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Spectral speech features may serve as noninvasive biomarkers for monitoring attention and executive function in major depressive disorder.

A set of 6 distinct midlife depressive symptoms appear to be associated with an increased risk for dementia later in life.

New research highlights socioeconomic and geographic barriers to telemental health care, despite its rapid expansion during the COVID-19 pandemic.

Prescription opioids may provide short-term anxiety relief for patients with chronic pain, especially among patients with cancer.

New reports suggest that apps like YouTube, TikTok, and other social media platforms are a constant in daily life for teens in the US.

Infection Control & Hospital Epidemiology recently published new guidance for infection prevention and control in nursing homes.

In-hospital nurses give mixed reviews on the efficacy of virtual nursing programs and their impact on hospital care.

Between 2011 and 2022, the proportion of pediatric care costs related to behavioral health increased from 22.4% to 40.2%, nearly doubling.

A new poll suggests that almost 1 in 4 Americans are concerned about the US health care system, the cost of care, and inaccessibility.

Compared with other methods, slow tapering paired with psychological support may be effective for preventing remitted depression relapse.